
Jianfeng Song
Examiner (ID: 5124, Phone: (571)270-1978 , Office: P/1613 )
| Most Active Art Unit | 1613 |
| Art Unit(s) | 1613 |
| Total Applications | 1010 |
| Issued Applications | 492 |
| Pending Applications | 125 |
| Abandoned Applications | 412 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18509889
[patent_doc_number] => 20230225974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => SOLID SOLUTION MADE FROM GUM ARABIC AND AT LEAST ONE LIPOSOLUBLE ACTIVE SUBSTANCE
[patent_app_type] => utility
[patent_app_number] => 17/998188
[patent_app_country] => US
[patent_app_date] => 2021-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2731
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998188
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/998188 | SOLID SOLUTION MADE FROM GUM ARABIC AND AT LEAST ONE LIPOSOLUBLE ACTIVE SUBSTANCE | May 10, 2021 | Pending |
Array
(
[id] => 17020801
[patent_doc_number] => 20210244672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => Ingestible Product and a Method of Using the Same
[patent_app_type] => utility
[patent_app_number] => 17/242759
[patent_app_country] => US
[patent_app_date] => 2021-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6203
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17242759
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/242759 | Ingestible Product and a Method of Using the Same | Apr 27, 2021 | Abandoned |
Array
(
[id] => 19256800
[patent_doc_number] => 12016829
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Pharmaceutical composition and method for treating seizure disorders
[patent_app_type] => utility
[patent_app_number] => 17/225654
[patent_app_country] => US
[patent_app_date] => 2021-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16932
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 248
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17225654
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/225654 | Pharmaceutical composition and method for treating seizure disorders | Apr 7, 2021 | Issued |
Array
(
[id] => 18725722
[patent_doc_number] => 20230339915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => MODULATORS OF ALPHA-1 ANTITRYPSIN
[patent_app_type] => utility
[patent_app_number] => 17/916388
[patent_app_country] => US
[patent_app_date] => 2021-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63822
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916388
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/916388 | MODULATORS OF ALPHA-1 ANTITRYPSIN | Apr 1, 2021 | Pending |
Array
(
[id] => 18491486
[patent_doc_number] => 11696891
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-11
[patent_title] => Glucono delta-lactone for treatment of vaginal fungal infections
[patent_app_type] => utility
[patent_app_number] => 17/218739
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 6978
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17218739
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/218739 | Glucono delta-lactone for treatment of vaginal fungal infections | Mar 30, 2021 | Issued |
Array
(
[id] => 18215191
[patent_doc_number] => 11590103
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Ascorbate in the prevention of statin induced vascular calcification
[patent_app_type] => utility
[patent_app_number] => 17/212171
[patent_app_country] => US
[patent_app_date] => 2021-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 4570
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17212171
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/212171 | Ascorbate in the prevention of statin induced vascular calcification | Mar 24, 2021 | Issued |
Array
(
[id] => 18295006
[patent_doc_number] => 20230104692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => DMEU ENHANCER
[patent_app_type] => utility
[patent_app_number] => 17/913747
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5417
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17913747
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/913747 | DMEU ENHANCER | Mar 21, 2021 | Pending |
Array
(
[id] => 16932606
[patent_doc_number] => 20210198495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => EDIBLE FUNCTIONAL COATINGS AND HYBRID POLYMER-BASED COATINGS FOR PHARMACY AND FOOD
[patent_app_type] => utility
[patent_app_number] => 17/201103
[patent_app_country] => US
[patent_app_date] => 2021-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9444
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17201103
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/201103 | Edible functional coatings and hybrid polymer-based coatings for pharmacy and food | Mar 14, 2021 | Issued |
Array
(
[id] => 18886436
[patent_doc_number] => 11865192
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-09
[patent_title] => Modified wound dressings
[patent_app_type] => utility
[patent_app_number] => 17/201898
[patent_app_country] => US
[patent_app_date] => 2021-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 26
[patent_no_of_words] => 37580
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17201898
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/201898 | Modified wound dressings | Mar 14, 2021 | Issued |
Array
(
[id] => 18477078
[patent_doc_number] => 11690802
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-04
[patent_title] => Ophthalmic emulsion
[patent_app_type] => utility
[patent_app_number] => 17/200043
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5240
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17200043
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/200043 | Ophthalmic emulsion | Mar 11, 2021 | Issued |
Array
(
[id] => 18365138
[patent_doc_number] => 20230146729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => ANIMAL FIBRE PRODUCT
[patent_app_type] => utility
[patent_app_number] => 17/910670
[patent_app_country] => US
[patent_app_date] => 2021-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6098
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17910670
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/910670 | ANIMAL FIBRE PRODUCT | Mar 8, 2021 | Pending |
Array
(
[id] => 17080457
[patent_doc_number] => 20210275463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => DACTINOMYCIN COMPOSITIONS AND METHODS FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA
[patent_app_type] => utility
[patent_app_number] => 17/193058
[patent_app_country] => US
[patent_app_date] => 2021-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24812
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17193058
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/193058 | Dactinomycin compositions and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemia | Mar 4, 2021 | Issued |
Array
(
[id] => 17065692
[patent_doc_number] => 20210267907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => WATER-SOLUBLE MICROENCAPSULATED CANNABINOID EXTRACT POWDER AND METHOD OF MAKING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/182871
[patent_app_country] => US
[patent_app_date] => 2021-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1743
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17182871
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/182871 | WATER-SOLUBLE MICROENCAPSULATED CANNABINOID EXTRACT POWDER AND METHOD OF MAKING THE SAME | Feb 22, 2021 | Abandoned |
Array
(
[id] => 18084290
[patent_doc_number] => 11534397
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Nanocrystal microparticles of poorly soluble drugs and methods of production and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/171151
[patent_app_country] => US
[patent_app_date] => 2021-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10986
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 310
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17171151
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/171151 | Nanocrystal microparticles of poorly soluble drugs and methods of production and use thereof | Feb 8, 2021 | Issued |
Array
(
[id] => 18351660
[patent_doc_number] => 20230139771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => Additive for Detoxification
[patent_app_type] => utility
[patent_app_number] => 17/912660
[patent_app_country] => US
[patent_app_date] => 2021-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17912660
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/912660 | Additive for Detoxification | Feb 3, 2021 | Abandoned |
Array
(
[id] => 17005376
[patent_doc_number] => 20210236537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => HIGH POROSITY CELLULOSIC STRUCTURES AND METHODS OF TREATMENT THEREWITH
[patent_app_type] => utility
[patent_app_number] => 17/166991
[patent_app_country] => US
[patent_app_date] => 2021-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4900
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17166991
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/166991 | HIGH POROSITY CELLULOSIC STRUCTURES AND METHODS OF TREATMENT THEREWITH | Feb 2, 2021 | Abandoned |
Array
(
[id] => 18200630
[patent_doc_number] => 11582996
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Plant extracts and therapeutic compounds in smoking utensils and in honey complexes
[patent_app_type] => utility
[patent_app_number] => 17/158360
[patent_app_country] => US
[patent_app_date] => 2021-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 6689
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17158360
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/158360 | Plant extracts and therapeutic compounds in smoking utensils and in honey complexes | Jan 25, 2021 | Issued |
Array
(
[id] => 16946536
[patent_doc_number] => 20210205227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => FORMULATIONS OF (R)-2-AMINO-3-PHENYLPROPYL CARBAMATE
[patent_app_type] => utility
[patent_app_number] => 17/154336
[patent_app_country] => US
[patent_app_date] => 2021-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9186
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17154336
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/154336 | Formulations of (R)-2-amino-3-phenylpropyl carbamate | Jan 20, 2021 | Issued |
Array
(
[id] => 16963143
[patent_doc_number] => 20210214642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => FRAGRANCE COMPOSITIONS CONTAINING NORBORNENE DERIVATIVES FOR PERSONAL CARE PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 17/149912
[patent_app_country] => US
[patent_app_date] => 2021-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5762
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17149912
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/149912 | Fragrance compositions containing norbornene derivatives for personal care products | Jan 14, 2021 | Issued |
Array
(
[id] => 18626615
[patent_doc_number] => 20230285409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => METHODS OF USING RHO KINASE INHIBITORS TO TREAT VASCULAR DEMENTIA
[patent_app_type] => utility
[patent_app_number] => 18/001514
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12989
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18001514
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/001514 | METHODS OF USING RHO KINASE INHIBITORS TO TREAT VASCULAR DEMENTIA | Jan 7, 2021 | Abandoned |